Remove clinical adhd
article thumbnail

High ADHD comorbidity rates offer opportunity for pipeline products to capture market: GlobalData

Express Pharma

Attention-deficit/hyperactivity disorder (ADHD) is a clinically heterogenous neurodevelopmental disorder with high rates of comorbidity with other childhood-onset psychiatric disorders as well as learning disorders. per cent for pediatric and adult ADHD patients, respectively. per cent and 28.3 per cent and 28.3

111
111
article thumbnail

STAT+: Many pediatric drug study results were never posted to a U.S. government database

STAT

Amid ongoing controversy over clinical trial transparency, a new analysis found that results of 43 studies involving thousands of children were never reported to a U.S. Another tested a drug for lowering aggression among children diagnosed with attention deficit hyperactivity disorder, or ADHD.

225
225
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Telehealth companies that prescribed controlled substances during the pandemic brace for business to change

STAT

  The public health emergency paved the way for these young companies — whose prescriptions range from ADHD medication to substance use disorder treatment and off-label ketamine for depression — to prescribe medicines without ever seeing a patient in-person.   Continue to STAT+ to read the full story…

article thumbnail

Akili’s gaming therapy improves attention in ADHD kids

pharmaphorum

Akili has published data backing the efficacy of its childhood attention-deficit hyperactivity disorder (ADHD) video game therapy EndeavorRx in the peer-review journal Nature Digital Medicine. . The post Akili’s gaming therapy improves attention in ADHD kids appeared first on.

Labelling 109
article thumbnail

Cingulate partners with Indegene for ADHD therapy

Pharmaceutical Technology

Biopharmaceutical firm Cingulate and life sciences commercialisation firm Indegene have entered into a joint commercialisation deal for the former’s attention-deficit/hyperactivity disorder (ADHD) therapy CTx-1301 (dexmethylphenidate).

article thumbnail

Free ADHD Medication Comparison PDF

Med Ed 101

ADHD is one of those areas that I don’t help with very frequently from a clinical standpoint. Dosage forms are a particular weakness in my ADHD skillset. I stumbled into this ADHD Medication […]. The post Free ADHD Medication Comparison PDF appeared first on Med Ed 101.

Dosage 40
article thumbnail

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done

pharmaphorum

October is ADHD Awareness Month, and retired NFL linebacker J.T. Thomas wants people to know that it is okay to get help for the treatment of attention deficit hyperactivity disorder (ADHD). As a person with ADHD, J.T. When I finally sought treatment in 2013, I learned how to turn my ADHD into a strength by better managing it.